[Questionnaire survey on patients receiving scheduled inpatient chemotherapy clarifies the issues of outpatient chemotherapy for advanced or recurrent colorectal cancer].
In recent 10 years, chemotherapy for advanced or recurrent colorectal cancer has progressed. FOLFOX and FOLFIRI regimens have been widely used for the patients with advanced colorectal cancer. Although these regimens can be administered without hospitalization via subcutaneous infusion reservoir, some patients prefer scheduled inpatient admissions for chemotherapy. In this study, we made a questionnaire survey for 11 patients receiving inpatient chemotherapy, which clarified the issues of outpatient chemotherapy for advanced and recurrent colorectal cancer.
Arakawa
Yasuhiro
Y
Dept. of Oncology and Hematology, Jikei University School of Medicine.
Sakuyama
Toshikazu
T
Ichiba
Tamotsu
T
Inoue
Daisuke
D
Kobayashi
Tadashi
T
Aiba
Keisuke
K
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010045:Outpatients; D012008:Recurrence; D011795:Surveys and Questionnaires
D000970:Antineoplastic Agents